These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature. Conant R; Schauss AG Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642 [TBL] [Abstract][Full Text] [Related]
4. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Fioravanti M; Yanagi M Cochrane Database Syst Rev; 2005 Apr; (2):CD000269. PubMed ID: 15846601 [TBL] [Abstract][Full Text] [Related]
5. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Fioravanti M; Yanagi M Cochrane Database Syst Rev; 2000; (2):CD000269. PubMed ID: 10796523 [TBL] [Abstract][Full Text] [Related]
7. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Fioravanti M; Yanagi M Cochrane Database Syst Rev; 2000; (4):CD000269. PubMed ID: 11034681 [TBL] [Abstract][Full Text] [Related]
8. Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Fioravanti M; Yanagi M Cochrane Database Syst Rev; 2004; (2):CD000269. PubMed ID: 15106147 [TBL] [Abstract][Full Text] [Related]
9. Citicoline, use in cognitive decline: vascular and degenerative. García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651 [TBL] [Abstract][Full Text] [Related]
10. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Hurtado O; Cárdenas A; Pradillo JM; Morales JR; Ortego F; Sobrino T; Castillo J; Moro MA; Lizasoain I Neurobiol Dis; 2007 Apr; 26(1):105-11. PubMed ID: 17234423 [TBL] [Abstract][Full Text] [Related]
11. Medical treatment of amblyopia: present state and perspectives. Campos EC; Fresina M Strabismus; 2006 Jun; 14(2):71-3. PubMed ID: 16760111 [TBL] [Abstract][Full Text] [Related]
12. Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease. Franco-Maside A; Caamaño J; Gómez MJ; Cacabelos R Methods Find Exp Clin Pharmacol; 1994 Oct; 16(8):597-607. PubMed ID: 7760585 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of oral CDP-choline. Drug surveillance study in 2817 cases. Lozano Fernández R Arzneimittelforschung; 1983; 33(7A):1073-80. PubMed ID: 6684470 [TBL] [Abstract][Full Text] [Related]
14. Effects of CDP-choline and the combination of CDP-choline and galantamine differ in an animal model of schizophrenia: development of a selective alpha7 nicotinic acetylcholine receptor agonist strategy. Deutsch SI; Rosse RB; Schwartz BL; Schooler NR; Gaskins BL; Long KD; Mastropaolo J Eur Neuropsychopharmacol; 2008 Feb; 18(2):147-51. PubMed ID: 17656074 [TBL] [Abstract][Full Text] [Related]
15. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Cansev M; Ilcol YO; Yilmaz MS; Hamurtekin E; Ulus IH Auton Autacoid Pharmacol; 2008 Jan; 28(1):41-58. PubMed ID: 18257750 [TBL] [Abstract][Full Text] [Related]